Most importantly, in various cancers, including pancreatic cancer, non-small-cell lung cancer, breast cancer and mesothelioma, high expression of LDH-A is correlated with significantly shorter patient survival [7,8,9]. This evidence concerns the gene LDHA and breast carcinoma.